[Federal Register Volume 70, Number 140 (Friday, July 22, 2005)]
[Notices]
[Page 42415]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-14541]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Notice of Intent To Grant an Exclusive License

AGENCY: Department of Veterans Affairs, Office of Research and 
Development.

ACTION: Notice of intent.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Department of Veterans 
Affairs, Office of Research and Development, intends to grant Global 
Therapy Monitoring LLC, 6931 Arlington Road, Bethesda, MD 20814 USA an 
exclusive license to practice the following patent applications: U.S. 
Provisional Patent Application Serial No. 60/547,052 filed February 25, 
2004, entitled ``Methods for Diagnosing and Treating Bladder Cancer''; 
U.S. Provisional Patent Application Serial No. 60/532,889 filed 
December 30, 2003, entitled ``Macrophage Migration Inhibitory Factor 
(MIF) as a Marker for Urological Inflammatory Disease''; U.S. Patent 
Application Serial No. 10/644,797 filed on August 21, 2003, and 
International Patent Application Serial No. PCT/US04/05288 filed on 
February 24, 2004, entitled ``Serum Macrophage Migration Inhibitory 
Factor (MIF) as a Marker for Prostate Cancer.''

DATES: Comments must be received within fifteen (15) days from the date 
of this published Notice.

ADDRESSES: Send comments to Saleem J. Sheredos, Acting Director of 
Technology Transfer, Department of Veterans Affairs; Office of Research 
and Development, Attn: 12TT; 103 South Gay Street, Baltimore, MD 21202. 
Telephone: (410) 962-1800 ext 267; Facsimile: (410) 962-2141; e-mail: 
[email protected].

FOR FURTHER INFORMATION CONTACT: Copies of the published patent 
applications may be obtained from the U.S. Patent and Trademark Office 
at http://www.uspto.gov.

SUPPLEMENTARY INFORMATION: It is in the public interest to so license 
these inventions as Global Therapy Monitoring LLC submitted a complete 
and sufficient application for a license. The prospective exclusive 
license will be royalty-bearing and will comply with the terms and 
conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive 
license may be granted unless, within fifteen (15) days from the date 
of this published Notice, the Department of Veterans Affairs Office of 
Research and Development receives written evidence and argument which 
establishes that the grant of the license would not be consistent with 
the requirements of 35 U.S.C. 209 and 37 CFR 404.7.

    Approved: July 13, 2005.
Gordon H. Mansfield,
Deputy Secretary of Veterans Affairs.
[FR Doc. 05-14541 Filed 7-21-05; 8:45 am]
BILLING CODE 8320-01-P